
Kalnem TZ 1000mg/125mg Injection
Marketer
Kalmia Healthcare
Salt Composition
Meropenem (1000mg) + Tazobactum (125mg)
Overview Kalnem TZ 1000mg/125mg Injection
Tazocin 1000mg/125mg Injection combines two antibiotics to combat serious bacterial infections affecting the skin, respiratory system, gastrointestinal tract, urinary system, bloodstream, central nervous system, and other areas. Its mechanism involves bacterial eradication and growth inhibition. Administration is strictly by a healthcare professional; self-injection is prohibited. Dosage and treatment length are tailored to infection severity, location, and type. Complete the prescribed injection course for optimal therapeutic effect; premature cessation may lead to relapse or infection exacerbation. Potential side effects include nausea, vomiting, diarrhea, rash, or localized injection site inflammation. These are typically transient, resolving with continued treatment. Persistent or bothersome side effects warrant medical consultation. Prior to commencing treatment, disclose any pre-existing conditions such as epilepsy, hepatic or renal impairment, or antibiotic allergies. Regular blood tests to monitor hematological parameters and renal function may be recommended. Pregnant or breastfeeding individuals should consult their physician to ensure treatment safety.
Primary Ingredients of Kalnem TZ 1000mg/125mg Injection
No text provided to rephrase.
Uses of Kalnem TZ 1000mg/125mg Injection
Managing life-threatening bacterial infections
Major Benefits of Kalnem TZ 1000mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Kalnem TZ 1000mg/125mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Injection site reactions (pain, swelling, redness)
How to use Kalnem TZ 1000mg/125mg Injection:
The medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Kalnem TZ 1000mg/125mg Injection works:
Meropenem, an antibacterial agent, functions by disrupting bacterial cell wall synthesis, a crucial process for bacterial survival. Tazobactam, a beta-lactamase inhibitor, counteracts bacterial enzymes (beta-lactamases) that otherwise would break down and render antibiotics ineffective.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Kalnem TZ 1000mg/125mg Injection lacks established safety data. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Data on the administration of Kalnem TZ 1000mg/125mg Injection to pregnant individuals is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the safety of Kalnem TZ 1000mg/125mg Injection while breastfeeding is lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Kalnem TZ 1000mg/125mg Injection on driving ability is undetermined. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Kalnem TZ 1000mg/125mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Kalnem TZ 1000mg/125mg Injection to individuals with hepatic impairment. Physician consultation is recommended.
What if you forget to take Kalnem TZ 1000mg/125mg Injection :
NA
Facts to Know About Kalnem TZ 1000mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Antimicrobial Agents |
